Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients

A Kober; M Dusleag; Daniela Kohlfürst; Daniela Ingrid Sperl; Volker Strenger; Martin Benesch; Wolfgang Schwinger

Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients

Research output: Contribution to conference book › Conference article

Original language	English
Publication status	Published - 2025
Event	51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) - Florence, Italy Duration: 30 Mar 2025 → 2 Apr 2025

Conference

Conference	51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Country/Territory	Italy
City	Florence
Period	30/03/25 → 2/04/25

Branches of science

302 Clinical Medicine
305 Other Human Medicine, Health Sciences

Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients
Kober, A. (Author), Dusleag, M. (Author), Kohlfürst, D. (Author), Sperl, D. I. (Author), Strenger, V. (Author), Benesch, M. (Author) & Schwinger, W. (Author)
2025
Activity: Talk, presentation or poster › Poster

Cite this

Kober, A., Dusleag, M., Kohlfürst, D., Sperl, D. I., Strenger, V., Benesch, M., & Schwinger, W. (2025). Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients. Paper presented at 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Florence, Italy.

@conference{2c84ce494e894792a7d8589f52d2558d,

title = "Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients",

author = "A Kober and M Dusleag and Daniela Kohlf{\"u}rst and Sperl, \{Daniela Ingrid\} and Volker Strenger and Martin Benesch and Wolfgang Schwinger",

year = "2025",

language = "English",

note = "51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; Conference date: 30-03-2025 Through 02-04-2025",

}

Kober, A, Dusleag, M, Kohlfürst, D , Sperl, DI , Strenger, V , Benesch, M & Schwinger, W 2025, 'Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients', Paper presented at 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Florence, Italy, 30/03/25 - 2/04/25.

Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients. / Kober, A; Dusleag, M; Kohlfürst, Daniela et al.
2025. Paper presented at 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Florence, Italy.

Research output: Contribution to conference book › Conference article

TY - CONF

T1 - Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients

AU - Kober, A

AU - Dusleag, M

AU - Kohlfürst, Daniela

AU - Sperl, Daniela Ingrid

AU - Strenger, Volker

AU - Benesch, Martin

AU - Schwinger, Wolfgang

PY - 2025

Y1 - 2025

M3 - Conference article

T2 - 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)

Y2 - 30 March 2025 through 2 April 2025

ER -

Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients

Conference

Branches of science

Activities

Off-label use of Letermovir for prophylactic, preemptive and therapeutic treatment of cytomegalovirus in paediatric allogeneic HSCT patients

Cite this